• The Boland Lab applies an integrated developmental and functional approach to model neurological disorders using human-induced pluripotent stem cells.

  • Frankel Lab is devoted to understanding the genetic basis of neurological disorders with an emphasis on epilepsy and a growing interest in closely related synaptic disorders that include seizures.

  • Research in the Gelinas Lab focuses on understanding the physiology of neural networks that mediate cognitive functions in the brain and how they are disrupted by epileptic activity.

  • Research in the Goldstein Lab covers a range of human genetics, from the identification of new disease-causing genes to development of treatment options that target the underlying causes of disease.

  • Research in the Harms Lab is focused on harnessing emerging genetic technologies to understand, identify, and model genes that cause inherited neuromuscular diseases.

  • The Makinson lab takes a multi-modal approach to understand the complex relationships between early developmental genetic impairments and evolving disease phenotypes.

  • The goal of Peng Lab is to understand the circuit and molecular mechanisms underlying sleep regulation in both normal and diseased brains.

  • The Tatonetti Lab uses advanced data science methods to investigate medicines. Using emerging resources, we are working to identify for whom drugs will be effective and for whom they will not.